Rx Item-Spravato Esketamine 56mg Kit Sn 28mg 2Unit Dose Package By Jom Pharmaceu
SPRAVATO® (esketamine) CIII Treatment Center | Treating Patients
SPRAVATO™ (esketamine) Nasal Spray Treatment) - Dr. Rafael Guerrero, Katy, TX
FDA approves Spravato, a fast-acting, Ketamine-like nasal spray to treat people with severe depression | South China Morning Post
SPRAVATO® (esketamine) CIII Nasal Spray: The First and Only N-Methyl D-Aspartate (NMDA) Receptor Antagonist Approved in Conjunction With an Oral Antidepressant for the Treatment of Adults With Treatment-Resistant Depression | Psychiatrist.com
Spravato Ketamine Treatment in NYC | Principium Psychiatry
These highlights do not include all the information needed to use SPRAVATO® safely and effectively. See full prescribing information for SPRAVATO®. SPRAVATO® (esketamine) nasal spray, CIII Initial U.S. Approval: 1970 (ketamine)
Spravato | Axis Integrated Mental Health
SPRAVATO™ (esketamine) - Nasal Spray, Now FDA Approved